Reversible lymphoma in the setting of azathioprine therapy for crohn's disease

New England Journal of Medicine

Volumn 331, Issue 13, 1994, Pages 883-884

  Larvol, Loic ^a   Soule, Jean Claude ^a   le Tourneau, Agnes ^b  

^a HÔPITAL LOUIS MOURIER   (France)

^b HÔTEL DIEU   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CORTICOSTEROID; IMMUNOSUPPRESSIVE AGENT; MERCAPTOPURINE; MESALAZINE;

ADULT; B CELL LYMPHOMA; BRAIN LYMPHOMA; CASE REPORT; CLINICAL TRIAL; CROHN DISEASE; EPSTEIN BARR VIRUS; HUMAN; LETTER; LYMPHOPROLIFERATIVE DISEASE; MALE; PRIORITY JOURNAL;

ADULT; AZATHIOPRINE; CASE REPORT; CROHN DISEASE; HERPESVIRIDAE INFECTIONS; HERPESVIRUS 4, HUMAN; HUMAN; LYMPHOMA, B-CELL; MALE; TUMOR VIRUS INFECTIONS;

EID: 0028147042     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJM199409293311321     Document Type: Letter

References (5)

1. Starzl TE, Nalesnik MA, Porter KA, Reversibility of lymphomas and lymphoproliferative lesions developing under cyclosporin-steroid therapy. Lancet 1984; 1: 583-587
2. Greenstein AJ, Mullin GE, Strauchen JA, Lymphoma in inflammatory bowel disease. Cancer 1992; 69: 1119-1123
3. Present DH, Meltzer SJ, Krumholz MP, Wolke A, Korelitz BI 6-Mercaptopurine in the management of inflammatory bowel disease: short- and long-term toxicity. Ann Intern Med 1989; 111: 641-649
4. Lemann M, Bonhomme P, Bitoun A, Messing B, Modigliani R, Rambaud JC Traitement de la maladie de Crohn par l'azathioprine ou la 6-mercaptopurine: etude retrospective chez 126 malades. Gastroenterol Clin Biol 1990; 14: 548-554
5. Hanto DW, Gajl-Peczalska KJ, Frizzera G, Epstein-Barr virus (EBV) induced polyclonal and monoclonal B-cell lymphoproliferative diseases occurring after renal transplantation: clinical, pathologic, and virologic findings and implications for therapy. Ann Surg 1983; 198: 356-369